Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis.

The Tohoku journal of experimental medicine - 1 Apr 2010

Lu Weixin, Feng Bo

Abstract excerpt

The receptor for advanced glycation end products (RAGE) is a multi-ligand member of the immunoglobulin superfamily and may be involved in the development of diabetic vascular complications. The -374T/A polymorphism in the RAGE gene promoter has been suggested to affect gene transcription. However, the studies on the association between the -374T/A polymorphism and vascular complications in type 2 diabetes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Vessels
Share to Databases, Factual
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetic Angiopathies

Share to Odds Ratio

Share to Receptor for Advanced Glycation End Products

Share to Receptors, Immunologic

Share to Risk Factors

Source

Identifiers

PMID: 20410680
DOI: 10.1620/tjem.220.291

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis.PMID 20410680Read ↗

Association between the RAGE (receptor for advanced glycation end-products) -374T/A gene polymorphism and diabetic retinopathy in T2DM.Semantic proximity Read ↗

Association of RAGE gene polymorphism with vascular complications in Indian type 2 diabetes mellitus patients.Semantic proximity Read ↗

-374 T/A polymorphism in RAGE gene is associated with onset of diabetes mellitus, atherosclerosis, and renal dysfunction in patients with hypertension.Semantic proximity Read ↗

The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients.Semantic proximity Read ↗

The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients.Semantic proximity Read ↗

A meta-analysis of receptor for advanced glycation end products gene: four well-evaluated polymorphisms with diabetes mellitus.Semantic proximity Read ↗

The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients.Semantic proximity Read ↗

Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.Semantic proximity Read ↗

Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis.Semantic proximity Read ↗

Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients.Semantic proximity Read ↗

Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.Semantic proximity Read ↗

Association between the RAGE gene -374T/A, -429T/C polymorphisms and diabetic nephropathy: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.